&w=3840&q=100)
Zydus enters biologics CDMO market with $125 million acquisitions
Zydus Lifesciences has announced its entry into the global biologics contract development and manufacturing organisation (CDMO) market with a planned acquisition of two manufacturing facilities from US-based Agenus for up to $125 million (around ₹1,070 crore).
Under the agreement, Zydus will acquire Agenus' biologics facilities in Emeryville and Berkeley, California, for an upfront payment of $75 million (₹642 crore). It will come with an additional $50 million (₹428 crore) payable over three years, contingent upon achieving certain revenue milestones.
The acquisition gives Zydus immediate biologics manufacturing capabilities and a base in California, considered a major hub for biotechnology in the US.
The company said the acquired facilities would allow it to offer end-to-end services from pre-clinical development through largescale commercial manufacturing. The CDMO business will be housed under a new independent entity.
As part of the transaction, Zydus will also become the exclusive contract manufacturer for two of Agenus' late-stage immuno-oncology candidates, Botensilimab and Balstilimab. It will hold the first right of negotiation for future pipeline products.
The acquired facilities include an experienced professional team, which Zydus plans to expand. The company said it expects to create additional jobs and contribute to the local economy of California.
Sharvil Patel, managing director, Zydus Lifesciences, said, 'The acquisition will give Zydus a strategic foothold in the US and enhance our ability to partner with innovation-centric entities, advancing new products and prioritising patient-centric solutions. This move strengthens our long-term biologics vision and positions us to better serve the needs of the global biopharmaceutical industry.'
According to estimates cited by Zydus, the global biologics CDMO market is projected to grow at a compound annual growth rate (CAGR) of 15.7 per cent between 2025 and 2034, reaching around $84.9 billion by 2034.
The market's growth is being driven by increasing complexity of therapies, a shift towards biologics, and limited manufacturing infrastructure among small biotech companies.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
42 minutes ago
- Business Standard
Xi's message to Trump: Rein in the hawks trying to derail the truce
By Daisuke Wakabayashi and Berry Wang During his phone call with President Trump, Xi Jinping leaned on a maritime analogy to try to salvage the fragile trade truce that seemed to be fracturing from a series of escalating punitive economic measures. The Chinese leader compared the relationship between the United States and China to a large ship, with the two men serving as powerful captains holding the rudder firmly to maintain the proper course. The analogy also came with a warning. Do not let others steer the ship off course and jeopardize the relationship. For weeks, the White House seemed to openly lobby for a direct conversation between the two leaders — a point underscored by China stating that Mr. Xi had agreed to the call on Thursday at Mr. Trump's behest. With the United States ratcheting up the pressure on Beijing with technology and other restrictions, China may have acquiesced partly out of concern in Beijing that the China hawks in Mr. Trump's administration were succeeding in undermining the truce, analysts said. 'China is quite concerned about this,' said Wu Xinbo, the dean of the Institute of International Studies at Fudan University in Shanghai. 'There has to be communication at the leadership level to stop the momentum of the rapid deterioration of the US-China relationship.' The call between Mr. Trump and Mr. Xi came at an especially precarious moment. Less than one month after the two countries agreed to roll back punishing tariffs for 90 days and negotiate a trade deal, the truce seemed to be crumbling. Want to stay updated on what's happening in China? Sign up for Your Places: Global Update, and we'll send our latest coverage to your inbox. China continued to throttle the exports of rare earth minerals, throwing the supply chains of US manufacturers into disarray. In response, the United States imposed restrictions on the sale of chip design software to China. It barred American companies from using artificial intelligence chips from the Chinese technology giant Huawei. It suspended some sales to China of components and software used in jet engines. In addition, the Trump administration proposed a plan to revoke visas for some Chinese students. Yun Sun, director of the China program at the Stimson Center, a Washington think tank, said China saw an opportunity to use 'top leader diplomacy' to send this message to Mr. Trump directly: 'Hold off your hawks. The responsibility is on the top leaders. If you want a good relationship, don't let your cabinet members or team run freely with their crazy ideas.' Mr. Wu, of Fudan University, said the measures taken by the United States since last month's trade agreement demonstrated how different members of the Trump administration were pursuing their own agendas, pointing to the Commerce Department imposing export controls and the State Department saying it would revoke visas. China has maintained a tough posture, refusing to back down in response to Mr. Trump's tariffs, unlike other countries that have treaded carefully so as not to antagonize the United States. In April, before the truce, Beijing engaged in a tit-for-tat tariff escalation, raising import duties on American goods to 125 percent after the United States pushed its taxes on Chinese imports to 145 percent. China appears ready to withstand the hardship from a prolonged trade war with the United States, with the economic levers to make life equally difficult for Americans and test Mr. Trump's resolve. At the same time, China has its own economic vulnerabilities and probably wants to avoid a full decoupling with the United States. The country's economy is struggling to rebound from a real estate crisis. Already grappling with high levels of youth unemployment, China's manufacturing sector, a key provider of jobs, could bear the brunt of a trade war that closes off the US market and escalates fears in the rest of the world about the flood of inexpensive Chinese imports. China had resisted overtures from Mr. Trump for direct engagement with Mr. Xi for months, reflecting Beijing's cautious approach. Mr. Xi may have accepted such a call now to buy his government more time to prepare for a prolonged fight. The two leaders seemed to take away different things from the call. In a post on social media, Mr. Trump implied that they had resolved the dispute over the export of critical minerals, but China's readout mentioned no such thing. China's official summary included a warning from Mr. Xi to Mr. Trump that the United States should handle the Taiwan issue 'prudently' to prevent a dangerous conflict, while Mr. Trump characterized the call as being focused almost entirely on trade. China has responded angrily to remarks by Defense Secretary Pete Hegseth last week urging America's Asian allies to work with the United States to deter China from trying to seize Taiwan, a self-governed island democracy. Mr. Trump and Mr. Xi did agree that both sides would work once again to implement the agreement from last month and that further talks for a more permanent deal would proceed. Mr. Trump also said the talks with China will now include Commerce Secretary Howard Lutnick, in addition to Treasury Secretary Scott Bessent and Jamieson Greer, the US Trade Representative. And Mr. Xi urged the United States to withdraw 'negative measures' against China. To some extent, China could claim a win from the call, as Mr. Trump seemed to soften his administration's stance on Chinese student visas. Last week, Secretary of State Marco Rubio, one of Mr. Trump's hawkish advisers, said the United States would 'aggressively' revoke the visas of Chinese students, specifically those associated with the Communist Party or studying in critical fields. But Mr. Trump, on Thursday, rolled out the red carpet. 'Chinese students are coming. No problem,' Mr. Trump said during a briefing from the Oval Office. 'It's our honor to have them.' Before the call, Mr. Trump wrote on social media that Mr. Xi was 'VERY TOUGH, AND EXTREMELY HARD TO MAKE A DEAL WITH.' In his summary of the call, Mr. Trump sounded gracious, noting that the two leaders had invited each other to visit their respective countries. Scott Kennedy, a senior adviser at the Center for Strategic and International Studies, a Washington research group, said the call could signal that the two countries had shifted into a 'fragile equilibrium' after having demonstrated their willingness to turn up the pressure on each other. Mr. Kennedy noted that China is the only country to win concessions from the United States since Mr. Trump launched his global 'reciprocal' tariff campaign in April. 'I think they feel they probably figured Trump out and that this is a manageable relationship,' he said. 'If this agreement falls apart again, they know what buttons to push to make the Trump administration take notice.'
Business Standard
42 minutes ago
- Business Standard
Hinduja Family Philanthropy: 250% Crop Yield Surge with Watershed Initiatives
VMPL New Delhi [India], June 6: Small farmers in rural West Bengal's core are experiencing a dramatic change due to the efforts of water management by the Hinduja Foundation (philanthropic arm of the Hinduja family). This farsighted plan has remarkably enhanced agricultural productivity, thereby creating an astonishing 250% increase in crop yields in a very short span of time. This outstanding achievement is the outcome of focused watershed interventions, designed in partnership with the Ambuja Foundation, that have been made to enhance water supply, improve soil health, and empower local farmers to escape the poverty cycle. The Power of Watershed Interventions For decades, farmers in West Bengal's Murshidabad district have coped with unpredictable rainfall and water shortage, severely constraining their capacity to cultivate high-value crops and maintain their livelihoods. Seeing the prospect of rewriting this story, the Hinduja Foundation introduced a series of watershed interventions to maximise water use and improve agricultural resilience. These were check dams, river lift irrigation schemes, or rainwater harvesting works designed according to the specific measurements and climatic characteristics of the local area. These systems cover more than 400 ha of cultivated land, which is an astonishing number in itself. Transforming Rural Livelihoods The numbers speak eloquently enough. Farmers have testified to stepped-up cropping intensity in the region by an incredible 250%, allowing them to raise more than one crop per year and their revenues manyfold. The average annual income per acre has gone up from Rs25,000 to Rs150,000, making farming a more and more remunerative and sustainable occupation. Prakash Hinduja, the managing trustee of the Hinduja Foundation, emphasized the significance of this initiative: "At the Hinduja Foundation, we are committed to making a sustainable development impact long after we have departed. We build rural empowerment and resilience, as demonstrated by our programs in Murshidabad." Building a Sustainable Future In addition to the economic advantages, watershed projects provide long-term environmental benefits. This project helps restore nature's ecological balance, making agriculture more sustainable in the long term with the prevention of soil erosion, recharge of aquifers, and enhancement of total water-holding capacity in the region. Switzerland-based Prakash Hinduja reinforced this by stating, "Water is needed for farming, and our activities are intended to enhance productivity while making farmers successful sustainably. This exactly suits our family vision of developing long-term value for communities." A Model for Pan-Indian Impact The Hinduja Foundation's work in Murshidabad is more than a local success story. It is a scalable model for similar interventions across India, particularly in regions facing water stress and climate challenges. By building the infrastructure for effective water management, the foundation is laying the groundwork for a more resilient nationwide agricultural sector. "We are envisaging a better future for all farmers in India," said Prakash Hinduja. "We are supporting innovations in water management technologies to enhance farmers' local community productivity, incomes, and resilience. This is the essence of the commitment to sustainable development embodied by the Hinduja Family." With the world tackling the acute water scarcity and global warming crises, Hinduja Foundation's West Bengal program presents a shining example of agriculture in the India of the future: one of sustainability, rural strength, and rich harvests that last.
Business Standard
42 minutes ago
- Business Standard
G.C Chemie Pharmie: Four Decades of Innovation and Trust in Pharmaceuticals and Nutraceuticals
India PR Distribution Mumbai (Maharashtra) [India], June 6: G.C Chemie Pharmie Pvt. Ltd. (GCCPL), a pioneer in India's pharmaceutical, nutraceutical, functional foods, and biopharmaceutical sectors, proudly celebrates over 44 years of innovation and service excellence. Founded in 1981 by visionary entrepreneur Gautam Shah, GCCPL has evolved into a globally connected and innovation-driven enterprise known for its commitment to trust, transparency, and quality. What began as an API trading and distribution firm has transformed into a diversified pharmaceutical powerhouse. GCCPL's impressive timeline of achievements includes: - 2009/2010: Acquisition of Eagle Chemical Works, establishing its own API manufacturing capabilities - 2009: Release of its first vaccine, marking a significant milestone in biopharmaceuticals - 2010/2011: Launch of its P2P division, introducing affordable medicines to the Indian market -2018: Entry into the sports nutrition space - 2022: Creation of a preventive healthcare division with a focus on gynecology and orthopedics - 2023: Establishment of a dedicated vaccine division to expand immunization solutions Driven by a mission to lead through innovative thinking and technology adoption, GCCPL delivers tailored solutions across pharmaceutical, nutraceutical, and functional food categories. The company continues to differentiate itself through its strong regulatory acumen, cutting-edge R & D, and a global network of manufacturing and distribution partners. "At GCCPL, innovation is not a buzzword--it's the foundation of our growth strategy," said Founder and Chairman Gautam Shah. "We're proud to be one of India's few private companies to bring the pneumococcal vaccine to the domestic market, second only to Pfizer." Recent product highlights include UC-II®, a patented undenatured type II collagen supplement, and Pylopass™, a breakthrough strain-based probiotic--both showcasing GCCPL's commitment to introducing clinically backed, innovative health solutions to India. With a sterling reputation for regulatory compliance, deep market research, and financial integrity--as affirmed by CRISIL's highest rating A2+ GCCPL stands as a trusted partner for businesses and healthcare providers seeking reliable, next-generation healthcare products. About G.C Chemie Pharmie Pvt. Ltd. Founded in 1981, GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global footprint. Known for its reliability, innovation, and commitment to quality, GCCPL offers customized, technology-driven healthcare solutions to meet the evolving needs of today's market. The company maintains a strong presence in vaccines, preventive care, functional foods, and advanced supplements.
